CD44 expression in melanocytic lesions: A marker of malignant progression?

British Journal of Dermatology

Volumn 135, Issue 6, 1996, Pages 876-882

  Harwood, C A ^a   Green, M A ^b   Cook, M G ^b  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOMA; METASTASIS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CANCER;

EID: 10544245026     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1996.d01-1089.x     Document Type: Article

References (35)

1. Stoolman LM. Adhesion molecules controlling lymphocyte migration. Cell 1989; 56: 907-10.
2. Underhill C. CD44: the hyaluron receptor. J Cell Sci 1992; 103: 293-8.
3. Gunthert U, Stauder R, Mayer B et al. Are CD44 variants involved in human tumour progression? Cancer Surv 1995; 24: 19-42.
4. Screaton GR, Bell MV, Jackson DG et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternately spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160-4.
5. Aruffo A, Stamenkovic I, Melnick M et al. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1310-13.
6. Stamenkovic IA, Aruffo M, Melnick CD et al. The haematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. Eur Mol Biol Organ J 1991; 10: 343-7.
7. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 1994; 180: 53-66.
8. Gunthert U, Hoffman W, Rudy S et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
9. Seiter S, Arch R, Reber S et al. Prevention of tumour metastasis formation by antivariant CD44. J Exp Med 1993; 177: 443-55.
10. Heider KH, Dammrich J, Skroch-Angel P et al. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993; 53: 4197-203.
11. Heider KH, Sinn HP, von Minckwitz G et al. Variants of CD44 in human breast cancer. In: Excerpta Medical International Congress Series. Amsterdam: Elsevier Science, 1993; 92.
12. Heider KH, Hofmann M, Hors E et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993; 120: 227-33.
13. Namec RE, Toole BP, Knudson T. The cell surface hyaluronate binding sites of invasive human bladder carcinoma cells. Biochem Biophys Res Commun 1987; 149: 249-57.
14. Horst E, Meijer CJLM, Radaszkiewicz T, Pals S. Adhesion molecules in the prognosis of diffuse large cell lymphoma: expression of lymphocytic homing receptor (CD44), LFA-1 (CD11/CD18), and ICAM-1(CD54). Leukemia 1990; 4: 595-9.
15. Biesold C, Kohler U, Horn LC et al. CD44 exon v6 as a predictor of lymphatic metastasis in cervical carcinoma - an immunocytochemical study of 94 cases. Arch Gynecol Obstet 1995; 256: 147-53.
16. Sy MS, Guo Y-J, Stamenkovic I. Distinct effects of two CD44 isoforms on tumour growth in vivo. J Exp Med 1991; 174: 859-66.
17. Hart IR, Birch M, Marshall JF. Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis Rev 1991; 10: 115-28.
18. Birch M, Mitchell S, Hart I. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res 1991; 51: 6660-7.
19. Guo Y, Ma J, Wang J et al. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 1994; 54: 1561-5.
20. East JA, Mitchell SD, Hart IR. Expression and function of the CD44 glycoprotein in melanoma cell lines. Melanoma Res 1993; 3: 341-6.
21. Fox SB, Gatter KC, Jackson DG et al. CD44 and cancer screening. Lancet 1993; 342: 548-9.
22. Clark WH, Elder DE, Guerry D et al. Model predictive survival in stage I melanoma based on tumour progression. J Natl Cancer Inst 1989; 81: 1893-904.
23. Wang C, Tammi M, Tammi R. Distribution of hyaluron and its CD44 receptor in the epithelia of human skin appendages. Histochemistry 1992; 98: 105-12.
24. Tsuji T. Mammary and extramammary Paget's disease: expression of Ca 15-3, Ka-93, Ca 19-9 and CD44 in Paget cells and adjacent normal skin. Br J Dermatol 1995; 132: 7-14.
25. Reed RJ. Minimal deviation melanoma. In: Pathobiology and Recognition of Malignant Melanoma. (Mihm MC, Murphy GF, Kaufman N, eds). Baltimore: Williams & Wilkins, 1988; 110-52.
26. Harris AJ, Wojnarowska F, Burge S et al. A study to examine the distribution of five CD44 isoforms in normal and diseased skin. Br J Dermatol 1995; 132: 652-3.
27. Matsamura Y, Tarin D. Significance of CD44 gene products for diagnosis and disease evaluation. Lancet 1992; 340: 1053-8.
28. Gross N, Bereta C, Peruisseau G et al. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res 1994; 54: 4238-42.
29. Favrot MC, Combaret V, Lasset C. CD44 - a new prognostic marker for neuroblastoma (letter). N Engl J Med 1993; 329: 1965.
30. Gross N, Beck D, Beretta C et al. CD44 expression and modulation on human neuroblastoma tumours and cell lines. Eur J Cancer 1995; 31A: 471-5.
31. Cook MG. Problems in the histological assessment of melanoma emphasising the importance of vertical/nodular component. Curr Diag Pathol 1994; 1: 98-104.
32. Herlyn M. Human melanoma: development and progression. Cancer Metastasis Rev 1990; 9: 101-12.
33. Natali P, Nicotra MR, Bavaliere R et al. Differential expression of intercellular adhesion molecule ICAM-1 in primary and metastatic melanoma lesions. Cancer Res 1990; 50: 1271-8.
34. Johnson JP. Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease. Int J Cancer 1991; 10: 11-22.
35. Mortarini R, Anichini A. From adhesion to signalling: roles of integrins in the biology of human melanoma. Melanoma Res 1993; 3: 87-97.